StocksFundsScreenerSectorsWatchlists
HQY

HQY - HealthEquity Inc Stock Price, Fair Value and News

81.75USD+2.03 (+2.55%)Delayed as of 28 Mar 2024, 11:01 am ET

Market Summary

HQY
USD81.75+2.03
Delayedas of 28 Mar 2024, 11:01 am
2.55%

HQY Alerts

  • 2 major insider sales recently.
  • Big jump in Earnings (Y/Y)

HQY Stock Price

View Fullscreen

HQY RSI Chart

HQY Valuation

Market Cap

6.9B

Price/Earnings (Trailing)

123.29

Price/Sales (Trailing)

6.87

EV/EBITDA

29.66

Price/Free Cashflow

28.48

HQY Price/Sales (Trailing)

HQY Profitability

EBT Margin

7.51%

Return on Equity

2.74%

Return on Assets

1.76%

Free Cashflow Yield

3.51%

HQY Fundamentals

HQY Revenue

Revenue (TTM)

999.6M

Rev. Growth (Yr)

12.21%

Rev. Growth (Qtr)

5.28%

HQY Earnings

Earnings (TTM)

55.7M

Earnings Growth (Yr)

12.7K%

Earnings Growth (Qtr)

79.68%

Breaking Down HQY Revenue

52 Week Range

48.8682.55
(Low)(High)

Last 7 days

-2.2%

Last 30 days

-2.0%

Last 90 days

21%

Trailing 12 Months

32.0%

How does HQY drawdown profile look like?

HQY Financial Health

Current Ratio

4.76

Debt/Equity

0.43

Debt/Cashflow

0.28

HQY Investor Care

Shares Dilution (1Y)

1.65%

Diluted EPS (TTM)

0.64

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024999.6M000
2023861.7M900.5M937.9M971.0M
2022756.6M778.0M795.1M831.2M
2021733.6M727.8M740.8M741.4M
2020532.0M635.0M724.4M746.6M
2019287.2M304.4M319.9M406.6M
2018229.5M244.0M258.2M271.9M
2017178.4M189.8M202.5M215.9M
2016126.8M140.9M154.6M167.4M
201587.9M97.5M107.1M115.8M
201462.0M67.6M73.5M80.1M
201346.1M50.1M54.1M58.0M

Tracking the Latest Insider Buys and Sells of HealthEquity Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 22, 2024
kessler jon
sold
-2,694,730
79.8084
-33,765
president and ceo
Mar 22, 2024
kessler jon
acquired
840,000
14.00
60,000
president and ceo
Mar 01, 2024
ladd delano
sold
-211,265
82.59
-2,558
evp, gc & corporate secretary
Feb 09, 2024
ladd delano
sold
-199,920
80.00
-2,499
evp, gc & corporate secretary
Feb 01, 2024
natarajan rajesh
acquired
-
-
1,124
-
Feb 01, 2024
parker stuart b.
acquired
-
-
1,058
-
Feb 01, 2024
dillon adrian t
acquired
-
-
1,455
-
Jan 08, 2024
ladd delano
sold
-181,020
70.00
-2,586
evp, gc & corporate secretary
Jan 05, 2024
ladd delano
sold (taxes)
-12,715
67.6367
-188
evp, gc & corporate secretary
Jan 05, 2024
rosner elimelech
sold (taxes)
-82,179
67.6371
-1,215
evp, chief technology officer

1–10 of 50

Which funds bought or sold HQY recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 26, 2024
Fairman Group, LLC
new
-
1,989
1,989
-%
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
reduced
-3.6
-84,240
589,209
-%
Mar 11, 2024
VANGUARD GROUP INC
added
1.22
-50,578,300
571,473,000
0.01%
Mar 04, 2024
TUCKER ASSET MANAGEMENT LLC
reduced
-75.00
-451
133
-%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
149
83,591,100
149,789,000
0.01%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-3.04
-1,416,670
10,393,300
0.04%
Feb 26, 2024
Neo Ivy Capital Management
sold off
-100
-263,000
-
-%
Feb 26, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
reduced
-2.66
-449,000
3,400,000
0.03%
Feb 21, 2024
Raleigh Capital Management Inc.
added
26.12
1,416
11,205
-%
Feb 16, 2024
Spouting Rock Asset Management, LLC
reduced
-5.06
-113,440
706,692
0.26%

1–10 of 46

Are Funds Buying or Selling HQY?

Are funds buying HQY calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own HQY
No. of Funds

Unveiling HealthEquity Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
10.05%
8,619,499
SC 13G/A
Feb 09, 2024
wasatch advisors lp
-
0
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 23, 2024
blackrock inc.
12.3%
10,591,921
SC 13G/A
Dec 08, 2023
vanguard group inc
10.05%
8,603,307
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G
Feb 09, 2023
vanguard group inc
9.83%
8,319,745
SC 13G/A
Feb 08, 2023
wasatch advisors inc
-
0
SC 13G/A
Feb 01, 2023
blackrock inc.
12.3%
10,422,979
SC 13G/A
Feb 11, 2022
jackson square partners, llc
0%
0
SC 13G/A

Recent SEC filings of HealthEquity Inc

View All Filings
Date Filed Form Type Document
Mar 26, 2024
144
Notice of Insider Sale Intent
Mar 26, 2024
4
Insider Trading
Mar 22, 2024
10-K
Annual Report
Mar 22, 2024
144
Notice of Insider Sale Intent
Mar 19, 2024
8-K
Current Report
Mar 13, 2024
8-K
Current Report
Mar 05, 2024
4
Insider Trading
Mar 01, 2024
144
Notice of Insider Sale Intent
Feb 21, 2024
8-K
Current Report
Feb 13, 2024
SC 13G/A
Major Ownership Report

What is the Fair Value of HQY?

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Cheap
or
Expensive?


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks

Peers (Alternatives to HealthEquity Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
454.6B
371.6B
-6.04% 4.38%
20.31
1.22
14.64% 11.24%
106.2B
195.3B
3.13% 30.55%
19.78
0.54
8.17% -20.79%
100.0B
357.8B
1.79% 0.39%
11.97
0.28
10.95% 93.52%
87.7B
65.0B
6.93% 30.56%
16.74
1.35
7.86% -7.11%
41.9B
154.0B
-2.30% 15.93%
15.51
0.27
6.54% 124.79%
12.6B
14.3B
11.30% 47.77%
17.56
0.88
6.59% 6.24%
12.0B
12.1B
9.73% 82.98%
17.36
0.99
4.57% 23.40%
MID-CAP
9.7B
2.3B
11.19% 28.50%
35.74
4.3
6.06% 9.17%
7.2B
2.9B
-7.72% 12.77%
-333.68
2.47
12.20% -107.93%
2.3B
3.8B
3.63% -32.94%
11.05
0.61
-27.73% -52.50%
2.3B
1.4B
3.04% 7.42%
37.6
1.65
21.19% 34.42%
SMALL-CAP
1.7B
1.1B
9.76% -2.01%
26.93
1.59
11.31% 35.83%
1.2B
3.0B
4.38% 103.39%
-6.6
0.41
6.74% 20.73%
56.3M
-
28.14% -20.98%
-3.85
-
- -12.94%
16.9M
20.7M
-2.22% -14.90%
83.48
0.82
6.53% -85.60%

HealthEquity Inc News

Latest updates
Defense World • 30 hours ago
Defense World • 23 Mar 2024 • 08:34 am
Seeking Alpha • 21 Mar 2024 • 03:55 pm
Seeking Alpha • 20 Mar 2024 • 12:43 am
Yahoo Finance • 19 Mar 2024 • 02:15 pm
StockNews.com • 18 Mar 2024 • 12:30 pm
Yahoo Finance • 15 Mar 2024 • 09:44 am

HealthEquity Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue5.3%26224924424423421620620620318018918418817917619020115787.0087.0076.00
Gross Profit3.1%16315815114813512711811110610311210310110510210811496.0058.0058.0044.00
Operating Expenses-2.4%12412812612512212112011813310411399.0010393.0093.0093.0099.0086.0034.0030.0028.00
  S&GA Expenses4.6%21.0020.0019.0020.0019.0017.0016.0017.0016.0013.0015.0014.0013.0013.0012.0011.0014.0013.008.009.008.00
  R&D Expenses-0.7%55.0056.0055.0053.0053.0049.0047.0045.0046.0038.0038.0035.0032.0031.0031.0031.0032.0024.0012.0011.0010.00
EBITDA Margin8.1%0.25*0.23*0.21*0.18*0.16*0.09*0.09*0.10*0.10*0.14*0.15*0.17*---------
Interest Expenses0.7%14.0014.0013.0015.0014.0012.0011.0010.0011.0012.007.007.007.007.009.0012.0014.0010.000.000.00-0.08
Income Taxes-47.7%3.006.004.006.000.00-4.54-3.22-4.41-10.95-4.09-3.97-3.45-6.712.00-0.540.00-0.42-9.924.009.003.00
Earnings Before Taxes40.9%30.0021.0014.0010.000.00-6.18-13.87-18.05-43.76-9.12-7.78-6.07-1.344.00-0.692.00-0.61-31.2524.0051.0016.00
EBT Margin60.8%0.08*0.05*0.02*-0.01*-0.04*-0.10*-0.11*-0.10*-0.09*-0.03*-0.01*-0.01*---------
Net Income79.7%26.0015.0011.004.00-0.21-1.64-10.65-13.64-32.82-5.04-3.82-2.615.002.00-0.152.00-0.19-21.3319.0042.0013.00
Net Income Margin85.7%0.06*0.03*0.01*-0.01*-0.03*-0.07*-0.08*-0.07*-0.06*-0.01*0.00*0.01*---------
Free Cashflow35.3%77.0057.0077.0031.0055.0047.0039.006.0049.0021.0033.0028.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets2.3%3,1643,0943,0663,0353,0893,0653,0743,0653,1073,1003,1493,1622,7102,6572,6642,5622,5652,5601,098597510
  Current Assets17.5%557474423358383332309279351764861865460396383284297270854365395
    Cash Equivalents20.9%404334290226254210177161225649754737329299269171192175815329361
  Net PPE-21.5%6.008.009.0011.0013.0016.0018.0021.0023.0025.0027.0027.0029.0032.0035.0036.0033.0035.0010.008.008.00
  Goodwill0%1,6481,6481,6481,6481,6481,6461,64636.001,6462821,3641,3641,3271,3271,3341,3331,3331,3235.005.005.00
Liabilities2.1%1,1291,1061,1171,1161,1931,1821,2091,2101,2551,2281,2861,3141,3321,3021,3241,5221,5351,54281.0067.0033.00
  Current Liabilities21.7%11796.0010390.0013111012611815310718519220515115413515214237.0023.0029.00
  Long Term Debt-100.0%-8748748739089119159199229248959109249399531,1671,1821,196---
    LT Debt, Current-----18.0015.0013.0011.009.007.0078.0063.0063.0063.0055.0047.0039.0031.00---
    LT Debt, Non Current0.1%8758748748739089119159199229248959109249399531,1671,1821,196---
Shareholder's Equity2.4%2,0351,9881,9501,9191,8961,8831,8651,8551,8531,8721,8631,8481,3791,3551,3401,0411,0301,0181,017529477
  Retained Earnings14.7%206179165154150150152162176209214218220215213213212212233214172
  Additional Paid-In Capital1.1%1,8291,8091,7851,7651,7461,7331,7131,6931,6771,6631,6491,6311,1581,1401,127827819806784316305
Accumulated Depreciation-10.6%41.0046.0045.0043.0042.0041.0040.0038.0036.0039.0036.0033.0031.0027.0023.0019.0016.0014.0011.0010.009.00
Shares Outstanding0.4%86.0086.0086.0085.0085.0084.0084.0084.0084.0084.0083.0082.00---------
Float-------4,300---6,100---3,900---5,700--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations35.0%77.0057.0077.0032.0055.0048.0040.007.0051.0022.0037.0031.0061.0052.0054.0015.0031.0017.0031.0025.0033.00
  Share Based Compensation-20.5%17.0022.0020.0018.0012.0018.0018.0014.0011.0013.0016.0013.0013.0011.0011.007.009.0018.008.006.006.00
Cashflow From Investing26.9%-11.27-15.42-10.25-9.13-10.28-13.53-21.12-74.20-471-79.68-20.47-67.80-20.23-21.03-30.40-25.29-25.10-1,646-6.86-61.7338.00
Cashflow From Financing102.9%4.002.00-2.15-51.03-1.15-1.09-3.393.00-2.97-47.220.00445-11.22-0.5775.00-10.3611.009894614.002.00

HQY Income Statement

2024-01-31
Consolidated statements of operations and comprehensive income (loss) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2022
Revenue   
Total revenue$ 999,587$ 861,748$ 756,556
Cost of revenue   
Total cost of revenue376,950369,813331,791
Gross profit622,637491,935424,765
Operating expenses   
Sales and marketing79,27368,84958,605
Technology and development218,811193,375157,364
General and administrative103,65697,47285,438
Amortization of acquired intangible assets92,76394,58682,791
Merger integration10,43528,59664,805
Total operating expenses504,938482,878449,003
Income (loss) from operations117,6999,057(24,238)
Other expense   
Interest expense(55,455)(48,424)(36,572)
Other income (expense), net12,7961,271(5,931)
Total other expense(42,659)(47,153)(42,503)
Income (loss) before income taxes75,040(38,096)(66,741)
Income tax provision (benefit)19,328(11,953)(22,452)
Net income (loss)55,712(26,143)(44,289)
Comprehensive income (loss)$ 55,712$ (26,143)$ (44,289)
Net income (loss) per share:   
Basic (in usd per share)$ 0.65$ (0.31)$ (0.53)
Diluted (in usd per share)$ 0.64$ (0.31)$ (0.53)
Weighted-average number of shares used in computing net income (loss) per share:   
Basic (in shares)85,56484,44283,133
Diluted (in shares)86,95784,44283,133
Service revenue   
Revenue   
Total revenue$ 455,690$ 452,026$ 443,608
Cost of revenue   
Total cost of revenue317,357318,516291,618
Custodial revenue   
Revenue   
Total revenue386,594261,282186,119
Cost of revenue   
Total cost of revenue32,50226,10119,492
Interchange revenue   
Revenue   
Total revenue157,303148,440126,829
Cost of revenue   
Total cost of revenue$ 27,091$ 25,196$ 20,681

HQY Balance Sheet

2024-01-31
Consolidated balance sheets - USD ($)
$ in Thousands
Jan. 31, 2024
Jan. 31, 2023
Current assets  
Cash and cash equivalents$ 403,979$ 254,266
Accounts receivable, net of allowance for doubtful accounts of $3,947 and $4,989 as of January 31, 2024 and 2023, respectively104,89396,835
Other current assets48,56431,792
Total current assets557,436382,893
Property and equipment, net6,01312,862
Operating lease right-of-use assets48,38056,461
Intangible assets, net835,948936,359
Goodwill1,648,1451,648,145
Other assets67,86852,180
Total assets3,163,7903,088,900
Current liabilities  
Accounts payable12,04113,899
Accrued compensation49,60845,835
Accrued liabilities46,03843,668
Current portion of long-term debt017,500
Operating lease liabilities9,40410,159
Total current liabilities117,091131,061
Long-term liabilities  
Long-term debt, net of issuance costs874,972907,838
Operating lease liabilities, non-current48,76658,988
Other long-term liabilities19,27012,708
Deferred tax liability68,67082,665
Total long-term liabilities1,011,6781,062,199
Total liabilities1,128,7691,193,260
Commitments and contingencies (see Note 7)
Stockholders’ equity  
Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of January 31, 2024 and 202300
Common stock, $0.0001 par value, 900,000 shares authorized, 86,127 and 84,758 shares issued and outstanding as of January 31, 2024 and 2023, respectively98
Additional paid-in capital1,829,3841,745,716
Accumulated earnings205,628149,916
Total stockholders’ equity2,035,0211,895,640
Total liabilities and stockholders’ equity$ 3,163,790$ 3,088,900
HQY
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.
 CEO
 WEBSITEwww.healthequity.com
 EMPLOYEES3170

HealthEquity Inc Frequently Asked Questions


What is the ticker symbol for HealthEquity Inc? What does HQY stand for in stocks?

HQY is the stock ticker symbol of HealthEquity Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of HealthEquity Inc (HQY)?

As of Wed Mar 27 2024, market cap of HealthEquity Inc is 6.87 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HQY stock?

You can check HQY's fair value in chart for subscribers.

What is the fair value of HQY stock?

You can check HQY's fair value in chart for subscribers. The fair value of HealthEquity Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of HealthEquity Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for HQY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is HealthEquity Inc a good stock to buy?

The fair value guage provides a quick view whether HQY is over valued or under valued. Whether HealthEquity Inc is cheap or expensive depends on the assumptions which impact HealthEquity Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HQY.

What is HealthEquity Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, HQY's PE ratio (Price to Earnings) is 123.29 and Price to Sales (PS) ratio is 6.87. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HQY PE ratio will change depending on the future growth rate expectations of investors.